跳至主要内容
临床试验/JPRN-jRCT1021210071
JPRN-jRCT1021210071招募中未知

An exploratory study of the relationship between dementia indicators and frontal EEG in normal subjects and patients with Alzheimer's disease

Takanami Kentaro0 个研究点目标入组 95 人开始时间: 2022年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
95

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 45age old 至 <= 80age old(—)
性别
All

入选标准

  • (1) Those who are between 45 and 80 years old at the time of obtaining consent.
  • (2) Those who have received sufficient explanation and understanding of this research, and who have given their free and voluntary consent in writing.
  • (1) Patients who are between 45 and 80 years of age at the time of consent.
  • (2) Patients who have been diagnosed with probable Alzheimer's disease (AD) according to the NIA-AA diagnostic criteria1).
  • (3) Those who have received sufficient explanation and understanding of this research and who have given their free and voluntary consent in writing. (4) A person who has been fully informed about this research and understands it, and who has given written consent of his/her own free will. Or, if the person lacks sufficient capacity to give consent, a person who has given written consent from a substitute.

排除标准

  • Healthy subjects
  • Those with a history of or complications from neurological diseases
  • Those who have performed MMSE or MoCAJ within 6 months
  • Those with mental illness
  • Those who are taking medication that may affect EEG measurement
  • Those with severe complications (malignant tumor, myocardial infarction, heart failure, etc.) that may affect the amyloid beta PET CT test and EEG measurement
  • Those whose physician judges that it is difficult to perform amyloid beta PET CT test due to some physical conditions (e.g., allergy to flutemetamol (18F))
  • Those who, for some reason (frontal trauma, frontal skin disease, skull defect, blindness, etc.), are considered to have difficulty in performing EEG measurement and tasks during EEG measurement
  • Pregnant women, nursing mothers, and those who wish to become pregnant during the research period
  • Those who are participating in other research.
  • Other persons whom the researcher, etc. judges to be undesirable as subjects of this research.
  • Patients with Alzheimer's disease
  • Patients with a history of or complications from neurological diseases other than Alzheimer's disease
  • Patients with mental illness
  • Patients who are taking medication that may affect EEG measurement
  • Patients with severe complications (malignant tumor, myocardial infarction, heart failure, etc.) that may affect amyloid beta PETCT test and EEG measurement
  • Patients whose physician judges that it is difficult to perform amyloid beta PET CT test due to some physical conditions (e.g., allergy to flutemetamol (18F))
  • Patients who, for some reason (frontal trauma, frontal skin disease, skull defect, blindness, etc.), are considered to have difficulty in performing EEG measurement and tasks during EEG measurement
  • Pregnant women, nursing mothers, and those who wish to become pregnant during the research period
  • Those who are participating in other research.
  • Other persons whom the researcher, etc. judges to be undesirable as subjects of this research.

研究者

发起方
Takanami Kentaro

相似试验